GÖRG Partnerschaft von Rechtsanwälten mbB and Walder Wyss advised Ufenau Capital Partners on the deal. Ufenau Capital Partners announced the investment in the Dr. Niedermaier Pharma Group....
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
